Latest news

U.S. funding cuts trigger steep drop in mRNA vaccine investment

U.S. funding cuts trigger steep drop in mRNA vaccine investment

Eduardo Longoria
Daily Snap - 6. October 2025

Daily Snap - 6. October 2025

Joachim Eeckhout
Cartography raises $67M to bring its first T cell engager into the clinic

Cartography raises $67M to bring its first T cell engager into the clinic

Eduardo Longoria
Galapagos nears decision on cell therapy unit sale amid investor interest

Galapagos nears decision on cell therapy unit sale amid investor interest

Eduardo Longoria
Daily Snap - 2. October 2025

Daily Snap - 2. October 2025

Joachim Eeckhout
Novartis wins FDA nod for Rhapsido, a first-in-class oral treatment for chronic hives

Novartis wins FDA nod for Rhapsido, a first-in-class oral treatment for chronic hives

Eduardo Longoria
Irish startup Aerska launches with $21M to break brain barriers in gene therapy

Irish startup Aerska launches with $21M to break brain barriers in gene therapy

Eduardo Longoria
Daily Snap - 1. October 2025

Daily Snap - 1. October 2025

Joachim Eeckhout
Star Therapeutics raises $125M to push next-gen bleeding disorder drug to market

Star Therapeutics raises $125M to push next-gen bleeding disorder drug to market

Eduardo Longoria
Crystalys launches with $205M to bring next-gen gout drug global

Crystalys launches with $205M to bring next-gen gout drug global

Eduardo Longoria
Daily Snap - 30. September 2025

Daily Snap - 30. September 2025

Joachim Eeckhout
Moonlake shares collapse after mixed trial results for key immune drug

Moonlake shares collapse after mixed trial results for key immune drug

Eduardo Longoria
FirstBack
1415161718192021
Next Last